Viewing Study NCT04762459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:47 PM
Ignite Modification Date: 2026-01-29 @ 4:37 AM
Study NCT ID: NCT04762459
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2022-02-24
First Post: 2021-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection
Sponsor: Chinese Academy of Medical Sciences
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Carcinoma View
Keywords: